Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer. Vlaming M, Koole W, van Moorselaar RJA, Bleiker EMA, et al. BJU Int 2025 Sep 2. doi: 10.1111/bju.16916.

Read + Share

Amedeo Smart

Independent Medical Education

Vlaming M, Koole W, van Moorselaar RJA, Bleiker EMA, et al. Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer. BJU Int 2025 Sep 2. doi: 10.1111/bju.16916.
PMID: 40891997